AI assistant
Sending…
Gain Therapeutics, Inc. — Director's Dealing 2021
Aug 18, 2021
34440_dirs_2021-08-17_a8e5b398-f1c5-4ea1-ae57-b06a9c566f8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Gain Therapeutics, Inc. (GANX)
CIK: 0001819411
Period of Report: 2021-08-16
Reporting Person: RICHMAN ERIC I (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-16 | Common Stock | M | 4922 | $7.866 | Acquired | 216820 | Direct |
More from Gain Therapeutics, Inc.
Regulatory Filings
2026
May 26
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 18
Investor Presentation
2026
Feb 3
Regulatory Filings
2025
Dec 18
Regulatory Filings
2025
Dec 3
Capital/Financing Update
2025
Nov 28
Capital/Financing Update
2025
Nov 28